Most significantly, on August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into law. The IRA includes provisions that will, among others: (i) direct CMS to negotiate the price of certain single-source prescription drugs reimbursed under Medicare, and subject drug manufacturers to civil monetary penalties and a potential excise tax by offering a price that is not equal to or less than the negotiated “maximum fair price” under the law; (ii) impose requirements on drug manufacturers to provide rebates to CMS under Medicare Part B and Medicare Part D as a penalty for price
All entries for: Nkarta, Inc.
November 10, 2025
Nkarta, Inc.
Neutral Outlook
South San Francisco, California
51-200 employees
Disease Area: Chronic Disease, Immune Diseases
Drug Type: Biologic
August 12, 2025
Nkarta, Inc.
Neutral Outlook
South San Francisco, California
51-200 employees
The IRA includes provisions that will, among others: (i) direct CMS to negotiate the price of certain single-source prescription drugs reimbursed under Medicare, and subject drug manufacturers to civil monetary penalties and a potential excise tax by offering a price that is not equal to or less than the negotiated “maximum fair price” under the law; (ii) impose requirements on drug manufacturers to provide rebates to CMS under Medicare Part B and Medicare Part D as a penalty for price increases that outpace inflation.
Disease Area: Multiple
Drug Type: Biologic